Hill Publishing Group | contact@hillpublisher.com

Hill Publishing Group

Location:Home / Journals / International Journal of Clinical and Experimental Medicine Research /

DOI:http://dx.doi.org/10.26855/ijcemr.2022.01.007

Progress of Traditional Chinese and Modern Medicine in Coronary Heart Disease

Date: December 20,2021 |Hits: 348 Download PDF How to cite this paper

Long Bai1,*, Jingjing Lei1, Junru Zhang2

1Shaanxi University of Traditional Chinese Medicine, Xianyang, 712046, Shaanxi, China.

2Shaanxi Provincial Hospital of Traditional Chinese Medicine, Xi’an, 710003, Shaanxi, China.

*Corresponding author: Long Bai

Abstract

Coronary atherosclerotic heart disease is referred to as coronary heart disease. It is a series of diseases in which coronary blood flow is blocked due to coronary artery lumen stenosis, which causes myocardial ischemia and hypoxia. The names of TCM diseases are “Chest Bi”, “Heartache” and so on. With the improvement of living conditions in our country, the incidence and mortality of coronary heart disease are on the rise, and at the same time it has caused a serious burden on my country’s medical treatment. In the process of combined treatment of CHD with traditional Chinese and Modern medicine in recent years, traditional Chinese medicine has shown its unique advantages. Modern medicine has made certain progress in pathogenesis based on previous developments. Traditional medicine has made new progress in the process of understanding CHD from qi stagnation and blood stasis to phlegm and blood stasis to the theory of heat toxin. Therefore, the research progress of Chinese medicine in CHD is summarized as follows.

References

[1] Hu Shengshou, Gao Runlin, Liu Lisheng, et al. (2019). Summary of “Chinese Cardiovascular Report 2018” [J].Chinese Journal of Circulation, 2019, 34(3), 209-220.

[2] Zhou Zhongying. (2011). Internal Medicine of Traditional Chinese Medicine [M]. 2 Edition. Beijing: China Press of Traditional Chinese Medicine, 2011: 79.

[3] Kinoshita, M., Yokote, K., Arai, H., et al. (2018). Japan Atherosclerosis Society (JAS) Guidelines for prevention of atherosclerotic cardiovascular diseases 2017 [J]. J Atheroscler Thromb, 2018, 25(9): 846-984.

[4] An Dongqing, Wu Zonggui, et al. (2021). Expert consensus on the prevention and treatment of atherosclerosis in traditional Chinese and western medicine [J]. Chinese Journal of Integrated Traditional Chinese and Western Medicine, 2021.

[5] Wu, H., Du, Q., Dai, Q., et al. (2018). Cysteine protease cathepsins in atherosclerotic cardiovascular diseases [J]. J Atheroscler Thromb, 2018, 25(2), 111-123.

[6] Mulvey, C. K., Mcneill, A. M., Girman, C. J., et al. (2014). Differential associations of oral glucose tolerance test-derived measures of insulin sensitivity and pancreaticb-cell function with coronary artery calcification and microalbuminuria in type 2 diabetes [J]. Diabetes Care, 2014, 37(1): 327-332.

[7] Kim, J. J., Hwang, B. H., Choi, I. J., et al. Aprospective two-center study on the associations between microalbuminuria, coronary atherosclerosis and long-term clinical outcome in asymptomatic patients with type 2 diabetes mellitus: evaluation by coronary CT angiography [J]. Int J Cardiovasc Imaging, 2014, 31(1): 193-203.

[8] Bokarewa, M., Nagaev, I., Dahlberg, L., et al. Resistin, an adipokine with potent proinflammatory properties [J]. J Immunol, 2005, 174(9): 5789-5795. DOI:10.4049/jimmunol.174.9.5789.

[9] Yu Yani, Liu Yuqi, Chen Yundai. (2021). Research Progress of Perivascular Adipose Tissue and Vascular Inflammation in Coronary Heart Disease [J]. Chinese Journal of Cardiovascular, 2021, 26(3): 294-298.

[10] Wang Chuanchi, Xu Weiming, Jiang Lijie, et al. (2021). A multi-center cross-sectional study on the distribution of phlegm and blood stasis in 11383 healthy people and patients with coronary heart disease at different stages [J]. Journal of Traditional Chinese Medicine, 2021, 62(6): 494-504.

[11] Xu Yilan, Gao Shan, Deng Bing, et al. (2018). The basic clinical and biochemical study of Danlou Decoction in intervention of coronary heart disease stable angina pectoris with phlegm and blood stasis syndrome [J]. Tianjin Traditional Chinese Medicine, 2018, 35(11): 808-812.

[12] Wang Shihan, Wang Jie, Li Ji, et al. (2012). Evaluation of the efficacy of Danlou Tablets in the treatment of angina pectoris of coronary heart disease with mutual obstruction of phlegm and blood stasis [J]. Chinese Journal of Integrated Traditional Chinese and Western Medicine, 2012, 32(8): 1051-1055.

[13] Hu Jingqing, Wang Chuanchi, Duan Fei, et al. (2016). Study on the Macroscopic Diagnostic Criteria of Coronary Heart Disease with Syndrome of Phlegm and Blood Stasis [J]. Chinese Journal of Integrated Traditional Chinese and Western Medicine, 2016, 36(10): 1164-1168.

[14] Liu Yue, Zhang Zhe, Zhang Huiyong, et al. (2017). Yang Guanlin’s theory of “phlegm and blood stasis” theory exerted [J]. Liaoning Journal of Traditional Chinese Medicine, 2017, 44(11): 2280-2283.

[15] Li Chengwei, Shen Shaogong. (2004). The overall treatment plan design for the treatment of phlegm and blood stasis in primary hypertension [J]. Chinese Medical Journal, 2004(10): 626-628.

[16] Liu Longtao, Chen Keji, Fu Changgeng, et al. (2015). Discussion on the etiology and pathogenesis of coronary heart disease from “toxin caused by blood stasis”. Chinese Journal of Integrated Traditional Chinese and Western Medicine, 2015, 35(11): 1378-1380.

[17] Liu Longtao, Chen Keji, Fu Changgeng, et al. (2004). Discussion on the etiology and pathogenesis of coronary heart disease from “toxin caused by blood stasis”. Chinese Journal of Integrated Traditional Chinese and Western Medicine, 2004, 28(6), 413-416.

[18] Chen Hang, Wang Jing, Fu Li. (2015). Effects of heat-clearing and detoxification method on blood lipids and serum indexes in patients with acute coronary syndrome [J]. Chinese Emergency in Traditional Chinese Medicine, 2015, 24(7), 1174-1175.

[19] Wang Song, Liu Yude, Li Rong, et al. Intervention of heat-clearing and detoxifying method on blood lipids, fibrinogen and D-dimer in 50 patients with atherosclerosis [J]. Shanxi Traditional Chinese Medicine, 2009, 24(6), 46-48.

How to cite this paper

Progress of Traditional Chinese and Modern Medicine in Coronary Heart Disease

How to cite this paper: Long Bai, Jingjing Lei, Junru Zhang. (2022) Progress of Traditional Chinese and Modern Medicine in Coronary Heart Disease. International Journal of Clinical and Experimental Medicine Research6(1), 40-42.

DOI: http://dx.doi.org/10.26855/ijcemr.2022.01.007

Volumes & Issues

Free HPG Newsletters

Add your e-mail address to receive free newsletters from Hill Publishing Group.

Contact us

Hill Publishing Group

8825 53rd Ave

Elmhurst, NY 11373, USA

E-mail: contact@hillpublisher.com

Copyright © 2019 Hill Publishing Group Inc. All Rights Reserved.